Data on Telehealth’s Role in Improving Peritoneal Dialysis Patient Care at ERA-EDTA 2017

High Acceptance of Advanced Healthcare Equipment Promoting Growth of a-Si X-ray Flat Panel Detectors | Fact.MR’s Medtech Analysis

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.

KA Imaging Makes Distribution Deal with Malaysia Based BeyMed

BeyMed is an emerging medical solutions company with a great potential,” said Amol Karnick, President and CEO of KA Imaging. Raises a $3M Series a Round to Scale Up Its Health Tech Platform in the MENA

The UK-based, MENA focused, startup closed $3M in its Series A round of funding led by MEVP with the participation of SOSF, IM capital and returning investors iSME, Cedar Mundi Ventures and IFA capital.
  • Physicians using SHARESOURCE remote patient management – a telehealth platform – have more accurate and timely visibility to their patients’ home therapy adherence
  • Remote patient management allows for earlier intervention in response to PD patient clinical issues
  • Nurses managing patients via remote patient management reported a 35 percent increase in time available to perform proactive patient-related tasks

Baxter International Inc. (NYSE: BAX) presented new data demonstrating the abilities of its SHARESOURCE remote patient management technology to improve peritoneal dialysis (PD) patient care and increase dialysis clinic efficiencies. The findings were shared at the 54th Congress of the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA), June 3-6.

Data show SHARESOURCE, a unique two-way, cloud-based technology platform that comes with the HOMECHOICE CLARIA automated PD (APD) system, is offering healthcare providers more accurate and timely visibility to their patients’ therapy adherence, allowing earlier discovery and intervention for clinical issues (Abstract #MP557). Additional data show the technology is associated with nurses gaining as much as 35 percent more time to perform proactive patient-related work (Abstract #SP508).

“Baxter’s SHARESOURCE remote patient management system was designed to support patients’ access to PD, with the confidence to perform home therapy knowing their healthcare providers are remotely managing their care,” said James Sloand, M.D., senior medical director, Baxter. “New data show the technology can help healthcare providers achieve this goal because they have timely access to accurate patient therapy adherence data, allowing them to address pertinent clinical issues earlier.”

The discrepancy between actual APD treatment time compared with prescribed treatment time (Abstract #MP557) was evaluated, because non-adherence (missing >10% of prescribed PD therapy (≥four treatments)) is associated with poor clinical outcomes, including, but not limited to peritonitis1,2 . The study included 399 European APD patients using remote patient management over a one-year period, and showed an average of 30 percent of patients were non-adherent in the first month on therapy.

An additional study determined remote patient management is associated with a change in the PD nursing paradigm, providing nurses more time to focus on proactive clinical management and better prioritize patients, and potentially support earlier interventions (Abstract #SP508). The observational study included more than 36 hours of monitoring the work routines of three PD nurses, each working at a different hospital. The nurses’ work routines were observed prior to the use of remote patient management and after the technology was established at their facilities.

Keeping Patients on PD Therapy

Preliminary results on early PD attrition from the PD Outcomes and Practice Patterns Study (PDOPPS) – a Baxter co-sponsored research effort looking at treatment and outcomes across seven countries – showed about 10 percent of PD patients drop out within 120 days (Abstract #MO061). Overall, catheter-related complications were the most frequent (21 percent) reason for patients to transfer to hemodialysis. Further patient recruitment and longer study follow up will allow PDOPPS to better understand the causes and develop recommendations to help patients stay on therapy longer.

Baxter’s SHARESOURCE has helped healthcare providers manage more than 700,000 PD patients’ home therapy sessions across the company’s HOMECHOICE CLARIA and AMIA APD systems. HOMECHOICE CLARIA with SHARESOURCE is available in select European, Asian and Latin American countries. SHARESOURCE is available with AMIA in the United States and Canada.




Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles